3-iodobenzylguanidine has been researched along with Rheumatic Heart Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amidon, TM; Dae, M; De Marco, T; Keith, F; Klinski, C; Kumar, S; Lau, D; Rifkin, C; Sudhir, K; Yuen-Green, MS | 1 |
1 other study(ies) available for 3-iodobenzylguanidine and Rheumatic Heart Disease
| Article | Year |
|---|---|
Iodine-123 metaiodobenzylguanidine scintigraphic assessment of the transplanted human heart: evidence for late reinnervation.
Topics: 3-Iodobenzylguanidine; Adult; Cardiomyopathy, Dilated; Female; Heart; Heart Failure; Heart Transplantation; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Middle Aged; Myocardial Ischemia; Myocardium; Nerve Regeneration; Norepinephrine; Radionuclide Imaging; Rheumatic Heart Disease; Sympathetic Nervous System | 1995 |